Vanguard Group’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $706K | Sell |
1,783,148
-34,854
| -2% | -$13.8K | ﹤0.01% | 3844 |
|
|
2025
Q1 | $631K | Sell |
1,818,002
-14,474
| -0.8% | -$5.02K | ﹤0.01% | 3829 |
|
|
2024
Q4 | $1.08M | Sell |
1,832,476
-52,776
| -3% | -$31.2K | ﹤0.01% | 3738 |
|
|
2024
Q3 | $3.32M | Hold |
1,885,252
| – | – | ﹤0.01% | 3410 |
|
|
2024
Q2 | $2.58M | Sell |
1,885,252
-213,785
| -10% | -$293K | ﹤0.01% | 3478 |
|
|
2024
Q1 | $7.22M | Buy |
2,099,037
+17,667
| +0.8% | +$60.8K | ﹤0.01% | 3135 |
|
|
2023
Q4 | $5.12M | Sell |
2,081,370
-20,946
| -1% | -$51.5K | ﹤0.01% | 3277 |
|
|
2023
Q3 | $3.57M | Buy |
2,102,316
+4,616
| +0.2% | +$7.85K | ﹤0.01% | 3387 |
|
|
2023
Q2 | $6.29M | Buy |
2,097,700
+174,325
| +9% | +$523K | ﹤0.01% | 3197 |
|
|
2023
Q1 | $5.15M | Sell |
1,923,375
-7,664
| -0.4% | -$20.5K | ﹤0.01% | 3295 |
|
|
2022
Q4 | $15.9M | Buy |
1,931,039
+522,807
| +37% | +$4.31M | ﹤0.01% | 2736 |
|
|
2022
Q3 | $10.8M | Buy |
1,408,232
+263,597
| +23% | +$2.03M | ﹤0.01% | 2920 |
|
|
2022
Q2 | $3.26M | Sell |
1,144,635
-411,647
| -26% | -$1.17M | ﹤0.01% | 3585 |
|
|
2022
Q1 | $7.78M | Sell |
1,556,282
-708,372
| -31% | -$3.54M | ﹤0.01% | 3279 |
|
|
2021
Q4 | $44.5M | Buy |
2,264,654
+175,631
| +8% | +$3.45M | ﹤0.01% | 2417 |
|
|
2021
Q3 | $61.5M | Buy |
2,089,023
+1,041,111
| +99% | +$30.7M | ﹤0.01% | 2243 |
|
|
2021
Q2 | $44.4M | Buy |
1,047,912
+43,841
| +4% | +$1.86M | ﹤0.01% | 2442 |
|
|
2021
Q1 | $51M | Buy |
1,004,071
+929,071
| +1,239% | +$47.2M | ﹤0.01% | 2305 |
|
|
2020
Q4 | $2.55M | Buy |
+75,000
| New | +$2.55M | ﹤0.01% | 3599 |
|